Multi-Strain Probiotic 20 Billion CFU + Fructo Oligosaccharides Capsules

The gut microbiome — comprising approximately 38 trillion microbial cells in the human gastrointestinal tract — functions as a metabolic organ, immune educator, and neuroendocrine regulator. MSVD Labs’ Multi-Strain Probiotic 20 Billion CFU + Fructooligosaccharides Capsules deliver a clinically meaningful diversity of bacterial strains paired with a prebiotic substrate to support microbiome restoration and maintenance. Multi-strain probiotic formulations demonstrate superior outcomes over single-strain products in clinical research, as different strains colonise distinct intestinal niches and contribute unique metabolic activities. Lactobacillus species support lactic acid production and mucosal barrier function in the small intestine, while Bifidobacterium species predominate in the colon and produce short-chain fatty acids (SCFAs) — particularly butyrate, the primary energy substrate for colonocytes. Fructooligosaccharides (FOS) serve as a selective fermentation substrate for beneficial bacteria, amplifying the colonisation and metabolic activity of supplemented strains without feeding pathogenic bacteria. This synbiotic combination (probiotic + prebiotic together) achieves superior microbiome modulation compared to probiotics administered alone. Clinical applications include antibiotic-associated diarrhoea prevention, IBS symptom management, traveller’s diarrhoea prophylaxis, and post-illness gut recovery. The gut-brain axis makes this formulation relevant to mental health, as SCFA production and vagal nerve signalling from the gut influence mood, anxiety levels, and cognitive function. Manufactured under WHO-GMP certification at MSVD Labs’ Surat facility. CFU count guaranteed at end of shelf life, not just at manufacture. Available in 10B, 20B, and 50B CFU variants. Custom strain selection for specialty B2B applications. Full documentation provided.